IDENTIFICATION OF BCR ABL-NEGATIVE STEM-CELLS WITHIN CML MARROW

被引：0
|
作者：
LEEMHUIS, T [1 ]
LEIBOWITZ, D [1 ]
COX, G [1 ]
SROUR, EF [1 ]
TRICOT, G [1 ]
HOFFMAN, R [1 ]
机构：
[1] INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202
来源：
EXPERIMENTAL HEMATOLOGY | 1992年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：782 / 782
页数：1
相关论文
共 50 条
  • [21] MECHANISMS OF TRANSFORMATION BY BCR/ABL IN PRIMARY CML CELLS
    GRIFFIN, JD
    OKUDA, K
    SATTLER, M
    UEMARA, N
    SALGIA, R
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 895 - 895
  • [22] Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34(+) cells
    Veena, P
    Cornetta, K
    Davidson, A
    Aguero, B
    McMahel, J
    Traycoff, CM
    Srour, EF
    BONE MARROW TRANSPLANTATION, 1997, 19 (12) : 1213 - 1221
  • [23] Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells
    P Veena
    K Cornetta
    A Davidson
    B Agüero
    J McMahel
    CM Traycoff
    EF Srour
    Bone Marrow Transplantation, 1997, 19 : 1213 - 1221
  • [24] A Pilot Study Of Bone Marrow and Adipose Tissue - Derived Mesenchymal Stem Cells In Chronic Myeloid Leukemia (CML); Mesenchymal Stem Cells Of The Bone Marrow Harbor The Bcr-Abl Fusion Gene In a CML Patient
    Papadopoulou, Vasiliki
    Peste, Korina
    Koumpi, Dafni
    Stavropoulou, Vasiliki
    Diamantopoulos, Panagiotis Theodorou
    Dimitroulis, Dimitrios
    Zervakis, Konstantinos
    Kalala, Fani
    Giannakopoulou, Nefeli
    Rougkala, Niki
    Hatzinikolaou, Polyxeni
    Tsilimidos, Gerasimos
    Iliakis, Theodoros
    Variami, Eleni
    Viniou, Nora-Athina
    BLOOD, 2013, 122 (21)
  • [25] BCR-ABL-POSITIVE AND BCR-ABL-NEGATIVE CLONOGENIC CELLS IN CML PATIENTS UNDERGOING LONG-TERM INTERFERON TREATMENT
    WANDL, UB
    BUTZLER, R
    NIEDERLE, N
    KLOKE, O
    MENGELKOCH, B
    BECHER, R
    SEEBER, S
    OPALKA, B
    LEUKEMIA, 1994, 8 (05) : 776 - 779
  • [26] BCR/ABL-negative chronic myeloproliferative disorders -: JAK2 mutation and beyond
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (08) : 1123 - 1125
  • [27] IDENTIFICATION OF NOVEL GENETIC ABERRATIONS IN BCR/ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS USING HIGH-RESOLUTION SNP ARRAYS
    Stegelmann, E.
    Bullinger, L.
    Kuhn, S.
    Schauer, S.
    Miller, S.
    Griesshammer, M.
    Dohner, H.
    Dohner, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 292 - 293
  • [28] Coincidence of bcr/abl-positive chronic myeloid leukemia and bcr/abl-negative chronic myelopioliferative disorder and its relevance to the course of disease
    Buesche, Guntram
    Bock, Oliver
    Hussein, Kais
    von Neuhoff, Nils
    Schlegelberger, Brigitte
    Kreipe, Hans H.
    BLOOD, 2007, 110 (11) : 867A - 867A
  • [29] PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice
    Peng, Cong
    Chen, Yaoyu
    Yang, Zhongfa
    Zhang, Haojian
    Osterby, Lori
    Rosmarin, Alan G.
    Li, Shaoguang
    BLOOD, 2010, 115 (03) : 626 - 635
  • [30] AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
    Zhou, Liang L.
    Zhao, Yun
    Ringrose, Ashley
    DeGeer, Donna
    Kennah, Erin
    Lin, Ann E. -J.
    Sheng, Guoqing
    Li, Xiao-Jiang
    Turhan, Ali
    Jiang, Xiaoyan
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11): : 2657 - 2671
12345